Psicofarmacología
Psicofarmacología 22:131, --------------- de 2022 regulation of lox-1 gene expression in vascular endothelium. Biochem. Biophys. Res. Commun. 281:720–725. • 15. Mass H, Pirazzi B, Gonzalez P, Collazo V, Fitzovich D, Avakian E. (1995). N-acetylcysteine diminishes injury induced by balloon angioplasty of the carotid artery in rabbits.Biochem. Biophys. Res. Commun. 215:613–618. • 16. Galle J, Heermeier K, Wanner C. (1999) Atherogenic lipoproteins, oxidative stress, and cell death. Kidney Int.56: S62–S65. • 17. Abello P, Fidler S, Buchman T. (1994) Thiol reducing agents modulate induced apoptosis in porcine endothelial cells. Shock 2:79–83. • 18. Clark J, Clore E, Zheng K, Adame A, Masliah E, Simon D. (2010). Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS ONE 5: e12333. • 19. Monti D, Zabrecky G, Kremens D, Liang T, Wintering N, Cai J et al. (2016) N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson’s Disease: Preliminary Clinical and Cell Line Data. PLoS One Jun 16;11(6): e0157602. • 20. González Llona I, Tumuluru S, González - Torres M, Gaviria M. (2015) Cocaína: una revisión de la adicción y el tratamiento. Rev. Asoc. Esp. Neuropsiq. 35 (127), 555-571. • 21. Gipson C, Reissner K, Kupchik Y, Smith A, Stankeviciute N, Hensley-Simon M et al. (2013) Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci U S A;110(22):9124–9. • 22. Baker D, McFarland K, Lake R, Shen H, Toda T, Kalivas P. (2003) N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann N Y Acad Sci.;1003:349–51. • 23. Palmatier M, Liu X, Donny E, Caggiula A, Sved A. (2008) Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology, 33(9):2139–47. • 24. Rao K, Sentir A, Engleman E, Bell1 R, Hulvershorn L et al. (2016) Toward early estimation and treatment of addiction vulnerability: radial armmaze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats. Psychopharmacology 233:3933–3945. • 25. Buttke T, Sandstrom P. (1994) Oxidative stress as a mediator of apoptosis. Immunol. Today 15; 7-10. • 26. Zaragoza A, Díez-Fernández C, Alvarez A, Andrés D, Cascales M (2001) Mitochondrial involvement in cocaine-treated rat hepatocytes: efect of N-acetylcysteine and deferoxamine. British Journal of Pharmacology 132, 1063 -1070. • 27. Graziani M, Antonilli L, Togna A, Grassi M, Badiani A, Saso L. (2016) Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress. Oxid Med and Cell Long. Vol 2016, Article ID 8408479, http: 10.1155/ 2016 / 8408479. • 28. Kerns W, Garvey L, Owens J. (1997) “Cocaine-induced wide complex dysrhythmia,” The Journal of EmergencyMedicine, vol.15 (3), 321–329. • 29. Khan M, Komolafe B, Weber K. (2013) “Cation interdependency in acute stressor states,” Am Journal of the Med Sciences, vol. 345 (5), 401–404. • 30. Lemasters J, Qian T, Bradham C. (1999) “Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death” J of Bioen and Biom, vol. 31, (4) 305–319. • 31. Xiao L, Pimentel D, Wang J, Singh K, Colucci W, Sawyer D. (2002) “Role of reactive oxygen species and NAD(P)H oxidase in a1-adrenoceptor signaling in adult rat cardiac myocytes,”Am J Phys-Cell Phys, vol.282, (4), 926-934. • 32. Pradhan L, Mondal D, Chandra S, Ali M, Agrawal K. (2008) Molecular analysis of cocaine-induced endothelial dysfunction: role of endothelin-1 and nitric oxide. Cardiovascular Toxicology, vol. 8 (4), 161–171. • 33. Badisa R,Goodman C , Fitch-Pye C. (2013) Attenuating effect of N-acetyl-L-cysteine against acute cocaine toxicity in rat C6 astroglial cells. Int J of Mol Med 32: 497-502. • 34. Kanel G, Cassidy W, L. Shuster L, Reynolds T. (1990) Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology, vol. 11- 4, 646–651. • 35. Moussawi K, Zhoua W, Shena H, Reichela C, See R, Carr D et al. (2011) Reversing cocaine-induced synaptic potentiation provides enduring protection from relapse. PNAS | January 4, vol. 108 (1) 385–390. • 36. Goldstein R, Volkow N (2002) Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159:1642– 1652. • 37. Kau K, Madayag A, Mantsch J, Grier M, Abdulhameed O, Baker D. (2008) Blunted cystine-glutamate antiporter function in the nucleus accumbens promotes cocaine-induced drug seeking. Neuroscience 155:530–537. • 38. Yang S, Salmeron B, Ross TJ, Xi Z, Stein E, Yang Y (2009). Lower glutamate levels in rostral anterior cingulate of chronic cocaine users - A (1)H-MRS study using TE-averaged PRESS at 3 T with an optimized quantification strategy. Psychiatry Res 174: 171–176. • 39. Schulte M, Wiers R, Boendermarker W, Goudriaan A, van den Brink W, van Deursen D et al. (2018) The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. Addict Behav 79: 24-31. • 40. Mardikian P, LaRowe S, Hedden S, Kalivas P Malcolm R. (2007) An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry; 31(2): 389-94. • 41. LaRowe S, Myrick H, Hedden S, Mardikian P, Saladin M, McRae A et al (2007) Is Cocaine Desire Reduced by N-Acetylcysteine? Am J Psychiatry; 164:1115–1117. • 42. LaRowe S, Kalivas P, Nicholas J, Randall P, Mardikian P, Malcolm R (2013) A Double-Blind Placebo-Controlled Trial of N-Acetylcysteine in the Treatment of Cocaine Dependence. The American Journal on Addictions, 22: 443–452. • 43. Levi Bolin B, Alcorn J, Lile J, Rush C, Rayapati A, Hays L et al. (2017) N-Acetylcysteine reduces cocaine-cue attentional bias and diff erentially alters cocaine self-administration based ondosing order. Drug Alcohol Depend; 178: 452-460. • 44. Schmaal L, Veltman D, Nederveen A, van den Brink W,Goudriaan A (2012) N-Acetylcysteine Normalizes Glutamate Levels in Cocaine-Dependent Patients: A Randomized Crossover Magnetic Resonance Spectroscopy Study. Neuropsychopharmacology 37, 2143–2152. • 45. Reichel C, Moussawi K, Do P, Kalivas P, See R. (2011) Chronic N-acetylcysteine during abstinence or extinction aft er cocaine self-administration produces enduringreductions in drug seeking. J Pharmacol Exp Ther; 337(2): 487-93. • 46. Madayag A, Lobner D, Kau K, Mantsch J, Abdulhameed O, Hearing M et al (2007) Repeated N-Acetylcysteine Administration Alters Plasticity- Dependent Effects of Cocaine. The Journal of Neuroscience, December 19, 27(51):13968 –13976. • 47. Garcia-Keller C, Smiley C, Monforton C, Melton S, Kalivas P, Gass J. (2020) N-Acetylcysteine treatment during acute stress prevents stress-induced augmentation of addictive drug use and relapse. Addict Biol; 25(5): e12798. • 48. Labib R, Abdel-Rahman M, Turkall, R (2003) N-acetylcysteine pretreatment decreases cocaine and endotoxin-induced hepatotoxicity. J Toxicol Environ Health A; 66(3): 223-39. • 49. Ducret E, Puaud M, Lacoste J, Belin-Rauscent A, Fouyssac M, Dugast E et al. (2015) N-acetylcysteine Facilitates Self-Imposed Abstinence After Escalation of Cocaine Intake. Biol Psyc August; 80:226–234. EDITORIAL SCIENS // 23
